tiprankstipranks
Trending News
More News >
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Cash flow

Compare
386 Followers

Evaxion Biotech Cash Flow

EVAX's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, EVAX's free cash flow was decreased by $4.84M and operating cash flow was $0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -12.94M$ -17.69M$ -25.77M$ -21.93M$ -12.44M
Investing Cash Flow
$ -3.00K$ -93.00K$ -268.00K$ -1.33M$ -393.00K
Financing Cash Flow
$ 13.13M$ 10.69M$ 7.85M$ 49.80M$ 8.82M
End Cash Position
$ 5.95M$ 5.58M$ 13.18M$ 32.17M$ 5.83M
Free Cash Flow
$ -12.94M$ -17.78M$ -26.07M$ -23.29M$ -12.83M
Currency in USD

Evaxion Biotech Cash Flow